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Viroporins are a group of transmembrane proteins with low molecular weight that are encoded by many animal viruses.
Generally, viroporins are composed of 50–120 amino acid residues and possess a minimum of one hydrophobic region
that interacts with the lipid bilayer and leads to dispersion. Viroporins are involved in destroying the morphology
of host cells and disturbing their biological functions to complete the life cycle of the virus. The 2B proteins encoded by
enteroviruses, which belong to the family Picornaviridae, can form transmembrane pores by oligomerization, increase the
permeability of plasma membranes, disturb the homeostasis of calcium in cells, induce apoptosis, and cause autophagy;
these abilities are shared among viroporins. The present paper introduces the structure and biological characteristics of
various 2B proteins encoded by enteroviruses of the family Picornaviridae and may provide a novel idea for developing
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12. References1. Introduction
As a consequence of long-term evolution, animal viruses
have acquired the ability to damage the normal physio-
logical functions of their host cells after infection to en-
sure their replication and the completion of their life
cycles. One of the damages inflicted is increased perme-
ability of the host cell membrane, a phenomenon induced
by the protein products of various viral genes, including
viral proteases such as non-structural protein 2B and non-
structural protein 3 of encephalitis B virus, glycoproteins,
and viroporins [1-4].
Viroporins are a family of low-molecular weight hydro-
phobic transmembrane proteins encoded by animal viruses.
Viroporins generally comprise 50–120 amino acid residues
and have a minimum of one transmembrane domain. The
transmembrane hydrophobic regions can interact with the
phospholipid bilayer to induce dispersion, thus increasing
membrane permeability and promoting the release of viral
particles [2-9]. With the increasing comprehensive studies
on viroporins, their functions in the life cycle of a virus have
gained significant attention. Currently, viroporins are im-
portant in promoting virus replication and in disruptingis is an Open Access article distributed under the terms of the Creative
mons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
al work is properly credited. The Creative Commons Public Domain
ublicdomain/zero/1.0/) applies to the data made available in this article,
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oligomerization of monomers in the membrane struc-
ture of host cells leads to the formation of hydrophobic
pores, which increase the permeability of the host cell
membrane and promote the budding of viral particles.
Moreover, viroporins affect the cell vesicular transport
system and glycoprotein transport process. In addition,
other studies have demonstrated that viroporins are in-
volved in destroying the shape of host cells and in dis-
turbing their normal physiological functions to ensure
completion of the entire viral life cycle. Virologists are
currently focusing on the biological functions of viro-
porins and their involvement in viral pathogenesis.
A study in 1992 showed that influenza A virus M2 pro-
tein exhibits viroporin activity and has important functions
in the viral life cycle [10]. Subsequently, proteins encoded
by other viruses, such as the non-structural protein 2B of
enterovirus, have similar characteristics [7]. In this review,
we summarize the virus infection mechanisms by introdu-
cing the topology of enterovirus non-structural protein 2B
and its biological features as a viroporin to provide new
ideas for studying and developing novel antiviral interven-
tion methods and drugs.2. Translation of enterovirus 2B protein
The Enterovirus genus belongs to the Picornaviridae
family, which includes poliovirus, Coxsackie virus, en-
teric cytopathogenic human orphan virus, and human
enterovirus 71 (EV71). Non-enveloped enterovirus is
spherical in shape, with a diameter ranging from 28 nm
to 30 nm. Its nucleocapsid is an icosahedron, and the
viral capsid consists of 60 copies of capsid proteins ar-
ranged into 12 pentamers. The genome of this virus
family contains a single-stranded positive-sense RNA
with 7500 to 8000 nucleotides and a single open read-
ing frame. RNA encodes a peptide chain with approxi-
mately 2200 amino acid residues. This peptide chain is
divided factitiously into three regions, P1, P2, and P3,
based on the differences in its structure and function.
P1 constitutes the capsid protein fraction of the virus,
whereas P2 and P3 comprise the non-structural pro-
teins of the virus. P1 is cleaved by the viral protease
Lpro into four viral capsid proteins: 1A (VP4), 1B (VP2),
1C (VP3), and 1D (VP1). The four structural proteins
envelop the viral RNA into the icosahedral capsid using
a highly ordered assembly process. The peptides in P2
and P3 initially generate three non-structured protein
precursors: 2BC, 3AB, and 3CD. Finally, these precur-
sors are cleaved into several non-structural proteins by
the following proteases (2Apro and 3Cpro): 2A, 2B, 2C,
3A, 3B (VPg), 3C, and 3D proteins (Figure 1) [11]. The
2B protein is one of the products from the polypeptides
in the P2 region.3. Transmembrane domain and membrane
topology of enterovirus 2B protein
Various studies have provided profound insights into
the viroporin structure. The currently accepted mode
of action for viroporin is the polymerization of mono-
mers to form hydrophilic pores and to exert their func-
tions after being embedded into the host cell membrane.
Viroporins can be divided into type I and type II based
on the presence of one or two transmembrane regions.
Moreover, both types can be further divided into sub-
types IA, IB, IIA, and IIB based on their transmem-
brane topology [12]. Figure 2 shows the four types of
viroporins. The N terminal of type IA viroporins faces
the organelle lumen, and the C terminal faces the cyto-
plasmic matrix (Figure 2A). By contrast, the C-terminus
of type IB viroporins faces the organelle lumen and the
N-terminus faces the cytoplasmic matrix (Figure 2B).
The C- and N-termini of type IIA viroporins stretch to
the organelle lumen (Figure 2C), whereas the C- and
N-termini of type IIB viroporins extend to the cyto-
plasm (Figure 2D).
Poliovirus 2B protein consists of approximately 100
amino acid residues and has two hydrophobic domains:
HR1 (32VTSTITEKLLKNLIKIISSLVIITG55) and HR2
(61TTTVLATLALLGCDASPWQWL81). For these two
hydrophobic domains, the HR1 domain crosses the cell
membrane via a cationic amphiphatic α-helix, whereas the
HR2 domain is a complete hydrophobic transmembrane
region [13]. The HR1 and HR2 domains of the protein are
located in the endoplasmic reticulum (ER) through an an-
gled annular serial connection by mutual cooperation,
such that the C- and N-termini of the polypeptide chain
stretch to the ER and Golgi lumen [13-15].
The Coxsackie virus-coded 2B protein is also a trans-
membrane protein with 99 amino acid residues and con-
sists of two hydrophobic domains: HR1 (37SILEKSLK
ALVKIISALV54) and HR2 (63LITVTATLALIGCTSSP
W80) [15,16]. HR1 forms a cationic amphiphilic α-helix,
whereas HR2 forms a completely hydrophobic helix [17].
Mutation analysis reveals that the lack of HR1 or HR2
causes the 2B protein to remain integrated with the host
cell membrane; however, translocation across the mem-
brane or oligomerization cannot be completed. The mu-
tant 2B protein without HR1 or HR2 has no biological
activity compared with the wild-type 2B protein [13,15].
These studies have demonstrated that the HR1 and HR2
domains are necessary for the interaction of the 2B pro-
tein with the membrane structure of the host cell. Two
hydrophobic domains and the stem loop connecting
them interact to form a “helix-angle-helix” structure.
After the interaction, the protein could successfully embed
into the membrane. Finally, normal oligomerization is
completed and transmembrane pores with biological func-
tion are formed [13].
Figure 1 Map of proteins encoded by the RNA of Enterovirus. The Enterovirus-code peptide chain is factitiously divided into three segments:
P1, P2, and P3. Peptide P1 is digested into four structural proteins: VP1–4, whereas peptides P2 and P3 are further digested into various
non-structural proteins.
Ao et al. Veterinary Research 2014, 45:87 Page 3 of 9
http://www.veterinaryresearch.org/content/45/1/87The poliovirus-coded 2B protein belongs to type IIB,
whereas Coxsackie virus-coded 2B protein is a member
of type IIA viroporins. This classification is based on the
membrane topologies and on the classification criteria
mentioned.
On the basis of the mutation of hydrophobic domains of
the enterovirus-coded 2B protein, we speculate that the in-
tegrality of these hydrophobic structures and the interac-
tions between them are crucial to the biological functions of
the 2B protein. These findings may provide a breakthrough
for future research and development of antiviral drugs.
4. Effects of the ion channel activity of
enterovirus 2B protein on host cells
After infecting susceptible cells with an animal virus, the
structure and function of the host cells significantly change.
These changes include increased intracellular vesicle for-
mation, increased membrane permeability, disrupted Ca2+
balance in cells, cell apoptosis, and induced autophagy
[5,13]. Some of these functional and morphological changes
can also be observed in cells expressing the enterovirus-
coded 2B protein only [9,13,18,19]. The viroporin features
of the 2B protein that affect the biological functions of host
cells are summarized in the following aspects.
4.1 Increases the permeability of the membrane structure
in host cells
Biochemical analysis of the enterovirus 2B protein se-
quence shows its two hydrophobic domains [15]. Self-polymerization reaction in a single lipid membrane
in vitro, in vivo yeast and mammalian cell two-hybrid
analysis, and fluorescence resonance energy transfer
microscopy of live cells confirm that the 2B protein is a
transmembrane protein [14,20]. Moreover, data ob-
tained from the biochemical analysis of the 2B protein
are highly consistent with its molecular dynamic data.
Previous studies have shown that the C- and N-termini
of poliovirus 2B protein are exposed to the ER and
Golgi lumen when expressed in cells [13-15]; however,
the C and N-termini of Coxsackie virus 2B protein are
located in the cytoplasm [15,16]. The 2B protein may
assemble into hydrophilic pores with diameters ranging
from 5 Å to 7 Å in the form of a tetramer in the lipid
bilayer [21]. When mutations are induced in the hydro-
philic domain (58RNHDD62) between HR1 and HR2 of
Coxsackie virus 2B protein, the protein cannot self-
polymerize in the lipid layer in vitro or in the host cell
membrane [14,22].
After being infected with an animal virus, a typical
pathological change of the host cells is the significant in-
crease in the permeability of the cellular membrane. The
increased permeability starts from the changes in Ca2+
content and the disruption of ionic gradients outside the
membrane [18]. When the enterovirus-coded 2B protein
is expressed independently in susceptible cells, cell per-
meability increases, such that non-specific selective ions
and solutes with low molecular weights (< 1000 Da)
freely flow in or out [12,13]. The increased membrane
Figure 2 Sketch map of the transmembrane topology of viroporins. The four types of viroporins based on their transmembrane topologies.
(A) and (B) represent type IA and type IB viroporins, respectively. These viroporins possess only one transmembrane domain with inverse
orientations. (C) and (D) represent type IIA and type IIB viroporins, respectively. These viroporins possess two transmembrane domains with
opposite orientations. Adapted from [12].
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cells overexpressing the 2B protein has been demonstrated
by the following experiments. The β-galactosidase in
Escherichia coli cannot be released and O-nitrophenyl β-
D-galactopyranoside (ONPG) cannot pass into E. coli
through the complete cell membrane under normal con-
ditions. However, after inducing the expression of the 2B
protein in E. coli BL21 (DE3), the addition of ONPG to
the bacterial culture suspension changes the color to
yellow [23]; its interaction with β-galactosidase forms a
yellow product. Second, the impermeable translation
inhibitor hygromycin B was used to reveal that the
virus-coded 2B protein can increase the permeability of
the membrane [24]. Furthermore, non-specific selective
ions and solutes with low molecular weights (< 1500 Da)
freely pass through the plasma membrane when poliovirus
2B protein is embedded into the liposomes or expressed
in BHK-21 cells; moreover, the intrinsic proton gradients
at both sides of the membrane are disturbed [9,13]. Simi-
lar to the function of poliovirus 2B protein, membrane
permeability increases after the 2B gene in Coxsackie virus
B3 was expressed in green monkey kidney cells [25]. Ex-
cept when proton gradients at both sides are destroyed
and when hygromycin B is allowed to freely flow outside,
the pH in the Golgi membrane evidently increases with
the development of infection [19]. All these studies have
proven that the 2B protein increases the permeability of
the host cell plasma membrane.
The following two mechanisms are initially hypothe-
sized to be responsible for the increase in cell membranepermeability: (1) after polypeptide chain cleavage, the
resulting mature protein covers the membrane surface
in a carpet pattern to destroy the bending degree of the
phospholipid bilayer, thereby affecting membrane perme-
ability; and (2) after polypeptide chain cleavage, the mono-
mers of the protein are formed. The oligomerization in
the membrane structure of host cells and the formation of
transmembrane pores subsequently occur to increase
membrane permeability [26]. The increased permeability
causes damage in the membrane structure of host cells.
This process is very important for the virus to complete
its life cycle. The increased cell membrane permeability
changes the original physiological state of the host cell
and facilitates the completion of replication and viral as-
sembly of a virus, as well as the budding of the progeny
virus. The enterovirus-coded 2B protein forms transmem-
brane pores that rely on the two hydrophobic transmem-
brane domains only. This established phenomenon affects
membrane permeability and has very important functions
in the viral life cycle.
4.2 Disturbs Ca2+ balance in host cells
Another significant effect of enterovirus 2B protein on
host cells is the disruption of Ca2+ balance in cells. Ca2+,
an important ion in cells, controls the activation of vari-
ous intracellular enzymes and is involved in their cata-
lytic processes. Ca2+ also has important functions in
viral replication and various physiological processes [27].
At normal physiological state, intracellular Ca2+ retains a
dynamic balance in the free and bound states. After
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tent in the cytoplasm increases. The 2B precursor 2BC
also exerts similar effect after being expressed in HeLa
cells [18]. Some studies have reported that the independ-
ent expression of Coxsackie virus 2B protein is sufficient
to increase the Ca2+ levels in the cytoplasm significantly
[28].
Preliminary studies have shown that the Ca2+ levels in
the cytoplasm increase in cells expressing the 2B protein
only, but the source of Ca2+ ions is unknown. Moreover,
Coxsackie virus infection induces a decrease in the Ca2+
content in the ER and Golgi, as well as a decrease in the
mitochondrial uptake of Ca2+ [28,29]. On the basis of
these observations, scholars have proposed two possible
mechanisms of the 2B protein: (1) induces the extracel-
lular Ca2+ inflow; and (2) disrupts the ER and Golgi
membranes to cause outflow of the stored Ca2+ ions into
the cytoplasm [30].
Ca2+–ATPase in the ER can transfer Ca2+ from the cyto-
plasm into the ER to compensate for the lost Ca2+. Using
thapsigargin to inhibit the activation of Ca2+–ATPase
in the ER reveals that the expressions of poliovirus and
Coxsackie virus 2B proteins in host cells promote Ca2+
outflow from the ER [18,30]. However, the increased
Ca2+concentration in the ER is mainly due to the extra-
cellular Ca2+ inflow [18].
Some studies used poliovirus to infect human neuro-
blastoma IMR5 cells, which grow in a culture medium
without Ca2+. As a result, the Ca2+ concentrations in the
ER increase [31]. Inhibiting the ryanodine receptor (RyR)
and inositol-1,4,5-triphosphate receptor (IP3R), which
control the Ca2+ inflow and outflow in the ER, decreases
the Ca2+ content in the cytoplasm. These results indicate
that the virus affects RyR and IP3R to alter the Ca2+ levels
[31]. However, no direct evidence has supported the con-
clusion that the 2B protein induces changes in the Ca2+
content. More complex mechanisms are possibly involved,
and further detailed investigations should be carried out.
4.3 Regulates apoptosis in host cells
Apoptosis is a process of cell death caused by various
stimuli, including virus infection. This process is achieved
via the following two pathways: (1) exogenous pathway,
where stimuli activate the death receptors Fas or CD95 on
the cell surface; and (2) endogenous pathway, where in-
creased permeability of the mitochondrial membrane
and ER stress occurs [32]. In the mitochondrial path-
way, the permeability of the mitochondrial membrane
increases. Transmembrane potential is disrupted, and
proapoptotic molecules are released [27].
An increasing number of studies have shown that the
Ca2+ exchange between the ER and mitochondria has a
very important function in the apoptotic process in the
ER-dependent pathway [27-29,33]. The excessivemitochondrial uptake of Ca2+ has toxic effects on cells;
high Ca2+ concentrations can open the mitochondrial per-
meability transition pores, expand mitochondrial perme-
ability, and rupture the mitochondrial outer membrane.
Consequently, cytochrome C and other pro-apoptotic fac-
tors are released, eventually leading to apoptosis (Figure 3).
Zhou et al. found that the expression of poliovirus and
Coxsackie virus 2B proteins can decrease the Ca2+ levels
in the ER, Golgi, and mitochondria [27]. De Jong et al.
also found a similar effect of Coxsackie virus 2B protein
on the efflux of Ca2+ in the Golgi apparatus [19]. This
effect possibly has two functions. The first function is
the inhibition of the protein transition pathway in cells
to promote viral replication and repression of the anti-
viral immune response of host cells. The decreased Ca2+
content in these organelles inhibits the transport of pro-
tein by the vesicles. The vesicles generated from the ER
or Golgi also accumulate in the cytoplasm. Viral RNA
replication occurs in the vesicles [27]. All viral proteins
required for RNA replication and the newly synthesized
viral RNA are associated with the surfaces of these
virus-induced vesicles. The cells infected with poliovirus
have many accumulated virus-induced vesicles. After
isolation from infected cells, the replication complex is
found in the center of a rosette-like cluster formed by
many virus-induced vesicles [35,36]. The replication
complex is attached to the vesicular membranes and is
enclosed through the plus strands of the replicative
intermediate protrude from the central part of the com-
plex. Finally, progeny 36S RNA is released on the surface
of the rosette [36]. In addition, the alphavirus RNA rep-
lication complexes on the surfaces of the membranous
vesicles have endosomal origin [37]. The formation of
the replication complexes requires active viral RNA rep-
lication. The membrane structure is essential for initiating
RNA synthesis reaction [36-38]. The second function is
temporary anti-apoptosis. After viral invasion, the apop-
totic program immediately starts in the cells. However, at
the middle stages of viral infection, apoptosis suddenly
stops. Mature apoptosis subsequently recovers at the late
stages of viral infection.
Poliovirus and Coxsackie virus can initiate the apop-
totic program in HeLa cells after infection through inhi-
biting intracellular transcription. However, at the start of
infection, the apoptosis of host cells suddenly stops with
the development of viral replication [29]. After viral
replication, the entire apoptotic signal becomes evident
[39]. These results demonstrate that apoptosis is partially
inhibited or delayed to ensure that viral replication pro-
cesses are completed after enterovirus infection.
Poly-(ADP-ribose) polymerase, a caspase-3 substrate,
is cleaved significantly in the poliovirus 2B protein-
expressing cells, and caspase-3 is activated subsequently.
The mitochondria in these cells expressing poliovirus 2B
Figure 3 Sketch map of apoptosis and autophagy induced by protein 2B. The 2B protein can embed into the cytomembrane, ER, and
mitochondrial membrane to increase cell permeability, disturb intracellular Ca2+ equilibrium, and ultimately induce apoptosis and autophagy of
host cells. Adapted from [26] and [34].
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long shape [5]. These results reveal that poliovirus 2B
protein can induce apoptosis. Moreover, the Coxsackie
virus 2B protein expressed in HeLa cells inhibits apop-
tosis caused by cycloheximide and actinomycin D [28].
An evidence also indicate that these phenomena are due
to the disruption of Ca2+ balance in cells caused by the
2B protein [29]. Moreover, the 2B protein forms trans-
membrane pores in the ER and Golgi membrane; thereby,
decreasing the Ca2+ content and generating extracellular
Ca2+ inflow. In addition, the uptake of Ca2+ by the mito-
chondrion decreases and the Ca2+ signal transmission be-
tween the ER and mitochondrion is disrupted; thus,
apoptosis is terminated. At the late stage of viral infection,
the permeability or potential energy of the mitochondrial
membrane is damaged and thus causes the mitochondria
to absorb the excess Ca2+ and release very high amounts
of cytochrome C [27]. The mature apoptotic signal in the
host cells was observed, and a mass of cytochrome C was
detected in the cytoplasm. The infected cells eventually
die, and viral particles are enclosed in the apoptotic bodies
whose phagocytosis by neighboring cells provide a poten-
tial method for viral distribution [40].
4.4 Regulates cell autophagy
The infected cells ultimately undergo apoptosis to re-
lease viral particles. However, at the start of viralinfection, apoptosis does not immediately occur to con-
tend with viral infection but autophagy occurs first. Au-
tophagy is a necessary process to balance the degrading
and reusing of the intracellular components in response
to nutritional deficiency and other stresses [41,42]. Some
studies have shown that cell autophagy can balance the
favorable and unfavorable effects of organism immunity
and inflammation to help organisms fight various conta-
gious autoimmune and inflammatory diseases [34]. Other
studies have also demonstrated that EV71 infection in-
creases the number of autophagosomes in cells and in-
hibits the cell apoptotic pathway [43]. A mass of viruses
are replicated during this period, which is similar to a
phenomenon observed when Coxsackie virus B3 is used
to infect cells [44].
Many viroporins, such as influenza A virus-encoded
M2 protein, rotavirus-encoded non-structure protein 1,
non-structural protein 4 (NSP4), and yellow fever virus-
encoded non-structural protein 4A, can induce cell au-
tophagy and inhibit cell apoptosis to promote viral
multiplication [45-48]. Studies on NSP4 of rotavirus
have demonstrated that the protein induces the release
of Ca2+ from the ER to the cytoplasm during viral repli-
cation. Ca2+/calmodulin-dependent protein kinases-β
kinases and 5′ adenosine monophosphate-related protein-
dependent signal pathways are activated resulting in cell
autophagy. However, the maturation of autophagosomes
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transfer viral proteins from the ER to the corresponding
replication and assembly sites [48]. The maturation of
autophagosomes is inhibited during enterovirus infection,
and intracellular vesicles become abundant during entero-
virus 2B protein process. The vesicles secreted from the
Golgi apparatus function as viral RNA replication sites
[27]. Other scholars have indicated that protein secretion
through the Golgi apparatus is inhibited to a certain ex-
tent [33]. Our research also found that autophagy is in-
duced after the cells were transfected with the plasmid-
encoded 2B protein of foot and mouth disease virus
FMDV (unpublished data).
5. Strategy for antiviral drug design based on
viroporins and other viral proteins with
viroporin-like activity
Over the recent years, studies have focused on the struc-
ture and functions of various viral viroporins; the studies
and design of antiviral drugs based on viroporins and
other viral proteins with viroporin-like activity have
made an important breakthrough. Currently, the devel-
opment of these antiviral drugs in this pathway mainly
focuses on three aspects. The first aspect is the design of
fusion inhibitors. The designed drugs can inhibit the fu-
sion of protein and cell membrane. Bosch et al. indicated
that the coronavirus-coded S protein is a transmem-
brane protein that pertained to type I viroporin. The
HR1 region of the S protein can inhibit the fusion be-
tween virus and cell membranes after mutation. The sec-
ond aspect is the design of the ion channel inhibitors.
These inhibitors can prevent viroporin activity to form
an ion channel. The inhibitory effect of amantadine on
influenza A virus M2 protein illustrates a good example.
The third aspect is the design of membrane protein anti-
bodies. The antibody that specifically affects membrane
proteins should be determined to inhibit viral invasion
by removing the protein or blocking membrane fusion.
Studies on human immunodeficiency virus-encoded en-
velope protein, known as gp160, confirmed the efficiency
of this method [49,50].
Four inhibitors inhibit the viroporin activity based on
these strategies. First, amantadine, a widely studied com-
pound, can inhibit the uncoating of influenza A viruses
by interacting with the M2 protein [51]. Amantadine is
located inside the virus M2 channel; amantadine local-
izes to the histidine gate and facilitates the orientation of
His37 imidazole rings to lie in the close conformation.
In addition, amantadine functions as a blocker when inter-
acting with three pore-lining residues: Leu26, Ala30, and
Ser31 [52,53]. Amantadine also inhibits the ion channel
activity of the p7 protein of Hepatitis C Virus (HCV) [54]
and the C-terminal subunit of the p13 protein (p13-C) of
the GB virus B (GBV-B), which is closely related to HCV[55]. Second, the long-alkyl-chain iminosugar derivatives
inhibit the HCV p7 protein to form an ion channel [56].
The results show that N-butyl-glucose analogue deoxyno-
jirimycin and N-nonyl-galactose analogue deoxygalacto-
nojirimycin, which contain the short-alkyl-chain, do not
affect the p7 channel activity. However, the long-alkyl-
chain derivatives, including N-nonyl-glucose analogue
deoxynojirimycin, N-nonyl-galactose analogue deoxyga-
lactonojirimycin, and N-7-oxanonyl-6-deoxy-DGJ, dose-
dependently inhibit the p7 channel signals with 105, 140,
and 180 μM, respectively [54,56,57]. Third, amiloride, a
drug used in the treatment of hypertension and con-
gestive heart failure, blocks the ion channel activity and
enhances the virus-like particle budding caused by human
immunodeficiency virus 1 (HIV-1) Vpu [58]. Moreover,
hexamethylene amiloride blocks the cation-selective ion
channels formed by the p7 protein of HCV [59]. Finally,
a novel small molecule, BIT225 (N-[5-(1-methyl-1H-
pyrazol-4-yl)-napthalene-2-carbonyl]-guanidine), has been
identified as a novel inhibitor of the HCV p7 ion channel
[60]. Compared with the effect of BIT225 on HIV-1 release
and the Vpu lacked HIV-2 from human macrophages,
scholars have found that BIT225 blocks the Vpu ion chan-
nel activity and also exhibits anti-HIV-1 activity [61].
The study on the 2B protein coded by virus from Picor-
naviridae family is relatively delayed. Moreover, the hydro-
phobic property and diversification of the membrane
topology of the 2B protein present many problems. How-
ever, cryo-electron microscopy, Fourier-transform infrared
spectroscopy, molecular dynamical analogs, and other
new technologies have been developed for antiviral drug
research; thus, current studies on antiviral drugs based on
the 2B protein mechanism considerably progress [62].
Some studies have reported that short-hairpin RNA can
affect the 2B gene of Coxsackie virus B3 and inhibit viral
replication [63]. Other studies have also demonstrated that
BHK cells expressing poliovirus 2B protein can increase
the permeability of neighboring normal cells by establish-
ing a “connection” between the cells [64]. All these find-
ings may provide novel methods for studying antiviral
drugs based on the 2B protein.
6. Conclusion and future perspectives
Previous studies demonstrated that enterovirus 2B pro-
tein has a role in pore formation, and preliminarily ana-
lyses on its effects on the viral life cycle were conducted.
However, the detailed functional mechanism of the 2B
protein requires further study. In particular, elucidating
the relationship of viroporin function with the signaling
pathway in cells and with regulatory proteins may pro-
vide novel information and basis for antiviral treatment
by selectively inhibiting specific pathways.
With more studies on the mechanism of enterovirus
2B protein accompanied with the emerging technologies
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quantum progress in the research and development of
novel antiviral drugs that target the 2B gene or protein
would be expected in the near future.
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